Navigation Links
Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
Date:8/16/2007

Prophylactic cranial irradiation after chemotherapy significantly reduces the risk of brain metastasis and doubles one-year survival in small-cell lung cancer (SCLC), according to the results of the multicenter phase III randomized EORTC trial 08993-22993, published in the New England Journal of Medicine today.

Small cell lung cancer (SCLC) is an aggressive tumor that constitutes nearly 15% of all newly diagnosed lung cancers. The majority of patients with SCLC present with extensive disease (ED) at diagnosis, meaning that the cancer has spread to other areas of the body. Without treatment, consisting of chemotherapy, the median survival is two to four months. Despite treatment, in most patients, disease progression will lead to dead within one year. Cancer spreading to the brain is an important cause of death and has a profound negative effect on psychological and physical functioning.

Background

Studies conducted primarily in the 1980 had shown that for patients with limited SCLC and complete response to chemotherapy, prophylactic brain irradiation reduced the risk of brain metastasis and improved survival.

In the EORTC 08993-22993 study, Ben Slotman, MD, PhD, Professor of Radiation Oncology at the VU University medical center in Amsterdam, and his European colleagues from the EORTC Radiation Oncology and Lung Cancer Groups extended the use of prophylactic cranial irradiation (PCI) to patients with extensive SCLC. 286 patients were randomized to either receive prophylactic irradiation or to being observed, following four to six cycles of chemotherapy that induced a response of their SCLC.

Results of the study

One year after being randomized in the trial, only 14.4 % of the patients that received PCI suffered from symptomatic spread of their cancer to the brain, compared with 40.4 % of the patients who did not receive PCI. Moreover, 27.1% of the patients receiving PCI were alive after one year, co
'/>"/>

Contact: Ben J Slotman
bj.slotman@vumc.nl
31-204-440-414
European Organisation for Research and Treatment of Cancer
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. New MRI Technique Measures Intracranial Pressure in Brain Disorder
2. Partial-Breast Irradiation an Unproven Therapy
3. Medulloblastoma Irradiation In Young Children Found To Impair IQ And Reading Skills
4. Risk of Thyroid cancer is increased after Childhood Irradiation of Neck region
5. Research Finds Lesser Rectal Cancer Risks Associated with Prostatic Irradiation
6. Smallpox as Biological Weapons?
7. Is Smallpox Threat Real ?
8. Smallpox Vaccine May Help Fight Cervical Cancer
9. Smallpox Would Spread Rapidly
10. Brain of Cocaine Addicts Smaller In Size
11. Problematic Use of smallpox vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ire-USNewswire/ -- The Generic,Pharmaceutical Ass...oday from,GPhA President and CEO Kathleen Jaeger ...dtable on "Emerging Health Care Competition and Co...TC is conducting this roundtable demonstrates the,...ave access to safe and,affordable biogenerics soo...
(Date:11/21/2008)...wswire-USNewswire/ -- New research at West Virgin...pitless tobacco product aimed at young adults is c... Reynolds, Camel Snus - touted as a socially accep...ngly high levels of nicotine. , , "Camel Sn...oducts," said Bruce Adkins of the state Division o...
(Date:11/21/2008)...RNewswire-FirstCall/ -- Today, prescription drugs ...reating 88 percent of patients suffering chronic c...r a chronic condition account for 96 percent of al... medical costs. A proprietary new pharmacy model ...ns, Inc. (NYSE: MHS ) significantly reduces crit...
(Date:11/21/2008)...In a statewide survey, 33 physicians credentialed ...Presbyterian Hospital of Dallas were honored by T...r Doctors ." , , Each year, the publishers ...a, Inc. to survey more than 38,000 medical profess...eeded medical care, which doctor would you choose?...
Breaking Medicine News(10 mins):Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2
...ion of sugars to proteins a process called glycos...alter, researcher of Temple University, believes ...tive diseases in humans. Currently, her lab is inv...oring the glycosylation process that could eventua...
...ently examined how researchers in Tanzania are tra...putum samples. The researchers' efforts "capitaliz..., according to the Times. Bart Weetjens, a former...idea of training rats to detect TB, as well as lan...
...ing an epidemic in Canada, researchers warn."Peopl...ier than in the past ," said Heather Ferguson, pre...nto. "I believe we're on the verge of noise induce... health crisis." Due to the prevalence of noise i...
...Advanced Medical Optics' voluntary recall on Frida...t lens solution, doctors of optometry from the Am... and Cornea Section concur with the company's deci...de. Although a cause has not been officially dete...
Other Medicine News:Health News:Nervous Systems of Insects may Offer Clues on Neurodegenerative Diseases 2Health News:Nervous Systems of Insects may Offer Clues on Neurodegenerative Diseases 3Health News:Researchers Training Rats To Diagnose TB 2Health News:Hearing Loss Becoming an Epidemic in Canada 2Health News:Hearing Loss Becoming an Epidemic in Canada 3Health News:Optometrists Support AMO's Voluntary Contact Lens Solution Recall 2
(Date:11/21/2008)... THOUSAND OAKS, Calif., Nov. 21 /PRNewswire-First...that the European Committee for Medicinal,Product...on recommending,marketing authorisation for Nplat...The CHMP recommends Nplate for adult chronic immun...enectomised patients who are refractory to,other ...
(Date:11/20/2008)... SAN MARINO, Calif., Nov. 20 Epei... Phase I/II and II studies of Rexin-G in,chemothe...osteosarcoma, as,presented by Dr. Sant P. Chawla,...meetings held in London UK on November 13-15, 2008... i.v. over a period up to 9 months. Analysis of,s...
(Date:11/20/2008)... , , , , PHILADELPHIA, Nov. 20 /P...K ) today announced that the United States Food an...proval for PROMACTA(R) (eltrombopag) for the treat...immune (idiopathic) thrombocytopenic purpura (ITP)...teroids, immunoglobulins or splenectomy. The appro...
(Date:11/20/2008)... RIVERSIDE, Calif., Nov. 20 Milk....better than originally thought. After years of,re...vered peptides found in,cow,s milk that stimulate..., To view the Multimedia News Release, go to:... , , While developing new cancer therapi...
Breaking Medicine Technology:Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 2Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 3Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 4Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 5Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 6Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 7Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 8Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2NYU American Museum of Natural History receive 241 6 million NSF grant 4686 1NYU American Museum of Natural History receive 241 6 million NSF grant 4686 2Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN 28R 29 7451 1Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN 28R 29 7451 2Unexplored Arctic region to be mapped 4685 1GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza 28R 29 7448 1GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza 28R 29 7448 2GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza 28R 29 7448 3GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza 28R 29 7448 4
...MINNEAPOLIS--(BUSINESS WIRE)--Apr 26, 2007 - A new...al of Child Neurology indicates,that a treatment f...children with cerebral palsy improves their qualit...established cost-effective,treatments. The finding...access to the treatment, known as Medtronic ITB Th...
...Two anti-aging preventative medicine doctors say t...their advocacy of prescribing,human growth hormone...th aging., DAYTONA BEACH, Fla., April 27, 2007 /PR... (HGH) was at the center of a recent New,York Time...my of,Anti-Aging Medicine (<a target="_blank" href...
Other Medicine Technology:Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 2Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 3Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 4Doctors Outraged Over Growth Hormone Controversy 2
Used for contralateral access to the iliac artery for interventional procedures after initial wire guide positioning has been established.,NOTE: Use of a heavy-duty wire guide is recommended.
Sheath Introducers with guidewires.
The Driver Stent design, utilizing an advanced cobalt-based alloy, surpasses the limitations of stainless steel stents. This stronger alloy makes possible thinner struts, for unparalleled flexibility
The complete performance package. Precision handling. Stable platform for device delivery. Enhanced backup support. Unique braid technology. Improved curve retention. Smooth PTFE liner.
Medicine Products: